5-amino-1mq peptide dosing protocol Therapy 5-Amino-1MQ Peptide Dosing Guide: Oral

An intradermal test dose is recommended before administration in patients suspected of being sensitive to the drug

It does not

(Most other peptides break down in the gut quickly and need to be injected to deliver an active drug.) Regulatory and safety status: KPV is not currently FDA approved for use and cannot be prescribed by an accredited, licensed clinician

Triple reuptake inhibitor mechanism What reuptake inhibition means: Neurotransmitters normally reabsorbed after release Reuptake inhibitors block this reabsorption Results in higher neurotransmitter levels Longer signaling duration Enhanced effects on target neurons Three neurotransmitters affected: 1